SPC

SpaceX is preparing its Starship rocket for its first orbital launch attempt. The flight would mark a major milestone for the company's next-generation, fully reusable heavy-lift rocket, which is central to NASA's Moon plans and Elon Musk's long-term ambitions for missions to Mars. Observers are watching closely for a launch date and for whether the vehicle can reach orbit on its first try.

Boeing is being described as showing early signs of a recovery in its space business, with financial commentary asking whether the company can narrow the gap with SpaceX, the dominant player in commercial spaceflight. The discussion, carried across finance outlets, weighs Boeing's recent progress against the scale of its rival's lead in launch and space operations.

Chosun Ilbo reports exclusively that the South Korean government is considering ending a national artificial intelligence project and is weighing a special purpose company structure as an alternative. The report has drawn attention to the fate of state-backed AI plans, with officials said to be reviewing whether the current approach should be abandoned or reorganised. Details of the project's scale and timeline were not disclosed.

Coverage claims SpaceX has gone public under the ticker SPCX and that shares jumped 19% in their debut, with analysts debating whether the stock can keep rising ahead of the company's first earnings report. Investors are weighing whether the post-IPO momentum is sustainable or driven by short-term hype. Note: SpaceX has not previously confirmed an IPO, so details remain uncertain.

The first lockup period following SpaceX's public listing has ended, and SPCX shares did not crash as some had feared. Attention is now turning to whether lingering supply overhang — early holders still waiting to sell — will weigh on the stock, with analysts divided on how much selling pressure remains in the market.

A Nature publication describes a rational framework for choosing between SpCas9 and variant-derived adenine base editors when editing the human genome. The work aims to help researchers match editor choice to specific target sites and desired edits, improving precision in gene-editing applications. The paper is being circulated among readers following advances in CRISPR-based genome editing tools.